Informations:
Erreur:
ID
14779
Description
Study Evaluating Bosutinib-Exemestane Combination Vs Exemestane Alone in Post Menopausal Women With Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00793546
Lien
https://clinicaltrials.gov/show/NCT00793546
Mots-clés
Versions (1)
- 27/04/2016 27/04/2016 -
Téléchargé le
27 avril 2016
DOI
Pour une demande vous connecter.
Licence
Creative Commons BY 4.0
Modèle Commentaires :
Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.
Groupe Item commentaires pour :
Item commentaires pour :
Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.
Eligibility Advanced Breast Cancer NCT00793546
Eligibility Advanced Breast Cancer NCT00793546
- StudyEvent: Eligibility
Similar models
Eligibility Advanced Breast Cancer NCT00793546
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
age
Item
woman aged 18 years or older.
boolean
C0001779 (UMLS CUI [1])
breast cancer
Item
confirmed pathologic diagnosis of breast cancer
boolean
C0678222 (UMLS CUI [1])
recurrent breast cancer
Item
locally advanced, metastatic, or locoregional recurrent breast cancer not amenable to curative treatment with surgery or radiotherapy.
boolean
C0278493 (UMLS CUI [1])
surgically sterile or postmenopausal woman
Item
surgically sterile or postmenopausal woman
boolean
C0021359 (UMLS CUI [1])
C0232970 (UMLS CUI [2])
C0232970 (UMLS CUI [2])
er+ and/or pgr+ and erbb2- tumor
Item
documented er+ and/or pgr+ and erbb2- tumor
boolean
C2938924 (UMLS CUI [1])
C2367479 (UMLS CUI [2])
C2367479 (UMLS CUI [2])
advanced or metastatic disease
Item
progression of locally advanced or metastatic disease during treatment with a nonsteroidal ai or tamoxifen, or progression during treatment with (or within 6 months of discontinuation of) an adjuvant nonsteroidal ai.
boolean
C0027627 (UMLS CUI [1])
C0039286 (UMLS CUI [2])
C0039286 (UMLS CUI [2])
exemestane, bosutinib
Item
prior exemestane, prior bosutinib, or any other prior anti-src therapy.
boolean
C0060116 (UMLS CUI [1])
C1831731 (UMLS CUI [2])
C1831731 (UMLS CUI [2])
endocrine treatment
Item
more than 1 prior endocrine treatment for locally advanced or mbc
boolean
C0038900 (UMLS CUI [1])
cytotoxic chemotherapy
Item
more than 1 prior cytotoxic chemotherapy regimen in metastatic setting.
boolean
C0677881 (UMLS CUI [1])
bone or skin
Item
bone or skin as the only site of disease.
boolean
C0391978 (UMLS CUI [1])
C1123023 (UMLS CUI [2])
C1123023 (UMLS CUI [2])